However, despite the ultimate decline in CD4 counts in pr& gression to AIDS, loss of TH function can occur years before CD4 counts drop to critical levels and AIDS symptoms appear (1 5-1 7). This loss in TH function is complex and sequential such that TH responses to REC, e.g. FLU and tetanus toxoid, occur before the loss of TH function to ALLO, which appears before the loss of response to the T a l l mitogen, PHA (16). Although this sequential loss in TH function was most extensively studied in adults, a similar pattern of decline in TH function has been reported in HIV-infected children (1 8). In the above studies, TH function was measured by 3H-thymidine incorporation &/or IG2 production. Similar results have been reported in whieb the proliferation of T cells stimulated with soluble a n t i 0 3 w*r laet before proliferation to insolubilized a n t i 0 3 (15). The lass of TH function to REC is predictive for a decline in CD4 oouafia in asymptomatic, HIV-infected (HIV+) adults but d m not appear to be associated with increased susceptibility to opportunistic infections (19). However, in pediatric patients with AIDS symptoms, the absence of TH function to REC is associated w& , susceptibility to backrial infections, and the loss of responsiness to PHA is associated with susceptibility to opporhudc infections (1 8). Although these early examples of TH dysregulation are not currently used as part of either the Centers for Disease Control or the Walter Reed staging critezia, they do, nevertheless, herald events pndictive for or associated with AIDS. Thus, we consider changes in T a l l fiunction to be relevant for AIDS development and instructive for u nsome of the earliest events of HIV-induced immune dysregdation. 
&te, the major emphasis has been placed on quantitative aspects of CD4 cells.
The mechanism(s) responsible for the decline in CD4 counts in individuals infkcted with HIV are still unmolved, although several proposals have been made to account for CD4 T-cell .
depletion. These include a direct cytopathic effect of HTV; cell Gsion and the formation of giant multinudeated cytolysis of idktd, or gpl20coated, CD4+ cells; autoimmunity; and programmed cell death or apoptosis (6-14).
However, despite the ultimate decline in CD4 counts in pr& gression to AIDS, loss of TH function can occur years before CD4 counts drop to critical levels and AIDS symptoms appear (1 5-1 7). This loss in TH function is complex and sequential such that TH responses to REC, e.g. FLU and tetanus toxoid, occur before the loss of TH function to ALLO, which appears before the loss of response to the T a l l mitogen, PHA (16) . Although this sequential loss in TH function was most extensively studied in adults, a similar pattern of decline in TH function has been reported in HIV-infected children (1 8). In the above studies, TH function was measured by 3H-thymidine incorporation &/or IG2 production. Similar results have been reported in whieb the proliferation of T cells stimulated with soluble a n t i 0 3 w*r laet before proliferation to insolubilized a n t i 0 3 (15). The lass of TH function to REC is predictive for a decline in CD4 oouafia in asymptomatic, HIV-infected (HIV+) adults but d m not appear to be associated with increased susceptibility to opportunistic infections (19). However, in pediatric patients with AIDS symptoms, the absence of TH function to REC is associated w& , susceptibility to backrial infections, and the loss of responsiness to PHA is associated with susceptibility to opporhudc infections (1 8). Although these early examples of TH dysregulation are not currently used as part of either the Centers for Disease Control or the Walter Reed staging critezia, they do, nevertheless, herald events pndictive for or associated with AIDS. Thus, we consider changes in T a l l fiunction to be relevant for AIDS development and instructive for u nsome of the earliest events of HIV-induced immune dysregdation. bath asymptomatic and symptomatic patients on AZT, 2) more 8 7 A n~c y t o r a P r i c m t r a t i b a d .~w i t h a l g r d Rqcaem Imaumd w2!-43
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